Leading hospital chain Apollo Hospitals Enterprises has reported a 52 per cent rise in its consolidated profit after tax at ₹372 crore for the quarter ended December 31, 2024, when compared with ₹245 crore in the year-ago period, supported by healthy growth in revenues and margins.
The board has declared an interim dividend of ₹9 per share (180 per cent of face value of ₹5 per share) for the year ended March 31, 2025.
The company’s consolidated revenue from operations grew by 14 per cent to ₹5,527 crore in Q3 of this fiscal when compared with ₹4,851 crore a year ago, driven by growth across all segments.
The company’s consolidated EBITDA rose 24 per cent to ₹762 crore in the December 2024 quarter as against ₹614 crore. This is after Apollo 24/7 cost of ₹141 crore in the quarter (including ₹27 crore non-cash ESOP charge) vs ₹156 crore in Q3FY24, according to a statement.
Revenues of healthcare services grew by 13 per cent to ₹2,785 crore (₹2463 crore in Q3FY24), AHLL (Apollo Health and Lifestyle Ltd) business saw its revenue grow 15 per cent at ₹389 crore (₹338 crore). Revenue of Apollo HealthCo grew by 15 per cent at ₹2,352 crore (₹2,049 crore) ₹366 crore and ₹2,082 crore respectively. However, AHLL incurred losses. Apollo HealthCo posted profit as against loss a year ago, while healthcare services remained profitable.
“With Q3FY25 revenues rising by 14 per cent and EBITDA by 24 per cent, our performance is a testament to our commitment of a healthier India by bringing cutting-edge technologies to everyone who needs it. We are on track to add 3,512 beds across 11 locations over 3 to 4 years beginning FY26. Our strategic partnership with Microsoft is accelerating our Al-driven healthcare transformation, including innovation in disease progression, and genomics, the statement said.
Consolidated PAT
For the 9-month period, Apollo Hospitals’ consolidated revenue grew by 15 per cent to ₹16,202 crore when compared with ₹14,115 crore in the same period year-ago. Its consolidated PAT grew by 64 per cent to ₹1,056 crore as against ₹645 crore.
As of December 31, 2024, Apollo Hospitals had 7,996 operating beds across the network (excluding AHLL & managed beds). The overall occupancy for hospitals was at 68 per cent vs 66 per cent in the same period in the previous year, aided by a strong increase in patient flows across hospitals.
The company’s shares closed at ₹6,766 apiece, down 0.3 per cent on BSE on Monday.
